Table 2 Histopathological parameter details
Parameter | Entire cohort (N = 144) |
|---|---|
Pathological T-classification (pT) | |
pT1 | 48 (33%) |
pT2 | 47 (33%) |
pT3 | 12 (08%) |
pT4 | 35 (24%) |
Not known | 02 (01%) |
Tumor grade | |
Low grade (grade I/II) | 108 (75%) |
High grade (grade III) | 20 (14%) |
Not known | 16 (11%) |
Perineural invasion (PNI) | |
Absent | 82 (57%) |
Present | 41 (29%) |
Not known | 21 (14%) |
Lymphovascular invasion (LVI) | |
Absent | 107 (74%) |
Present | 13 (09%) |
Not known | 24 (17%) |
Depth of Invasion (DOI) (mm) | |
Median (range) | 10 mm (10–30) |
≤ 10 mm | 69 (48%) |
> 10 mm | 57 (40%) |
Not known | 18 (12%) |
Pathological nodal staging (pN) (N = 141) | |
pN0 | 69 (48%) |
pN1 | 27 (18%) |
pN2 | 45 (32%) |
Node metastasis (N = 141) | |
Negative (pN-ve) | 69 (49%) |
Positive (pN+ve) | 72 (51%) |
Extra-capsular extension (ECE) (N = 141) | |
Absent | 102 (72%) |
Present | 33 (24%) |
Not known | 06 (04%) |
Margin status | |
Negative | 114 (79%) |
Positive or close | 27 (19%) |
Unknown | 03 (02%) |